Pakistan Mounts Vaccination Program Aimed At Hib In Children
This article was originally published in PharmAsia News
Pakistan plans a vaccination program to protect children in the country against five diseases, including a haemophilus influenza type that kills 23,000 a year in the country. The new combination is to be administered under a one-shot pentavalent program that includes protections against hepatitis B, diphtheria, pertussis and tetanus. Hib, which can cause meningitis and pneumonia, is considered one of the top causes of death in children in the developing world. (Click here for more
You may also be interested in...
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.
The FDA emphasized the rigor of its review of the first COVID-19 therapy, which used few expedited pathways on its way to approval after a two-and-a-half-month review. Post-marketing studies will address remaining concerns about dosing and special populations.